Showing 9,381 - 9,400 results of 16,891 for search '(( 50 we decrease ) OR ( 50 ((((ng decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 0.71s Refine Results
  1. 9381
  2. 9382
  3. 9383
  4. 9384
  5. 9385
  6. 9386
  7. 9387
  8. 9388
  9. 9389
  10. 9390
  11. 9391
  12. 9392
  13. 9393
  14. 9394
  15. 9395

    DataSheet1_Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction Model.pdf by Marian Wesseling (8807429)

    Published 2021
    “…<p>Cardiorenal syndrome type 2 is characterized by kidney failure as a consequence of heart failure that affects >50% of heart failure patients. …”
  16. 9396

    datasheet1_In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis.docx by Dahara Keyse Carvalho Silva (9774635)

    Published 2020
    “…In vitro incubation with LASSBio-1386 reduced the percentage of Leishmania-infected macrophages and the number of intracellular parasites (EC<sub>50</sub> = 9.42 ± 0.64 µM). Also, in vivo treatment of BALB/c mice infected with L. amazonensis resulted in a decrease of lesion size, parasitic load and caused histopathological alterations, when compared to vehicle-treated control. …”
  17. 9397

    Supplementary file 1_Influence of circadian rhythm on the determination of the IMMune age indeX (IMMAX).docx by Sina Trebing (22578458)

    Published 2025
    “…</p>Methods<p>Therefore, we conducted an experimental study with 50 participants aged 20–69 years and took blood samples at 8 a.m., 1 p.m. and 6 p.m. to determine the IMMAX over the day. …”
  18. 9398

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 9399

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  20. 9400

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”